Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-24T00:25:50.052Z Has data issue: false hasContentIssue false

Role for GLUT1 in diabetic glomerulosclerosis

Published online by Cambridge University Press:  06 February 2006

Charles W. Heilig
Affiliation:
Department of Medicine, University of Chicago Hospitals, Chicago, IL, USA.
Frank C. Brosius
Affiliation:
Department of Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Carol Cunningham
Affiliation:
Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

Abstract

Numerous studies have investigated specific pathways that link diabetes and high extracellular glucose exposure to glomerulosclerosis and mesangial cell extracellular matrix production. However, only in the past ten years has a role for glucose transporters in this process been addressed. Many different glucose transporters are expressed in glomeruli; of these, the GLUT1 facilitative glucose transporter is upregulated in the diabetic renal cortex and in response to glomerular hypertension, as well as in cultured mesangial cells exposed to high glucose. Transgenic mouse and cell models have recently been developed to test the role of GLUT1 in the pathogenesis of glomerulosclerosis with and without diabetes. Clinical studies of GLUT1 alleles performed in humans have identified GLUT1 susceptibility alleles for diabetic nephropathy. Studies are also currently under way to assess the potential role of GLUT1 in nondiabetic renal disorders.

Type
Review Article
Copyright
Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)